Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 3Breast 2Tumor-Agnostic 1Genitourinary 1

Conditions

Colorectal Neoplasms 2Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Patient Education as Topic × Gastrointestinal × Clear all
NCT06669923 2024-11-01

SSB and CRC

University of Virginia

Phase NA Not yet recruiting
120 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02582918 2022-09-28

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

University of Texas Southwestern Medical Center

Phase NA Completed
2,871 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01072851 2012-09-07

Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Trinity Health Of New England

Phase 3 Completed
920 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡